Search research articles
Contact Us
Filters
Showing results (91-100 of 124) with videos related to
Page
of 13
Sort By:
Proceedings of the National Academy of Sciences of the United States of America
|
March 27, 2009
Gene deregulation and spatial genome reorganization near breakpoints prior to formation of translocations in anaplastic large cell lymphoma
Stephan Mathas, Stephan Kreher, Karen J Meaburn, et al.
Cancers
|
January 10, 2026
Brentuximab Vedotin in Advanced-Stage Mycosis Fungoides/Sézary Syndrome with Low CD30 Expression: Real-World Data from the German Cutaneous Lymphoma Network
Christoph Blazejak, Mathias Oymanns, René Stranzenbach, et al.
Blood
|
May 22, 2023
Dimethyl fumarate treatment in relapsed and refractory cutaneous T-cell lymphoma: a multicenter phase 2 study
Jan P Nicolay, Susanne Melchers, Jana D Albrecht, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
April 8, 2010
Phase II clinical trial of intratumoral application of TG1042 (adenovirus-interferon-gamma) in patients with advanced cutaneous T-cell lymphomas and multilesional cutaneous B-cell lymphomas
Reinhard Dummer, Stefan Eichmüller, Sylke Gellrich, et al.
The Journal of Experimental Medicine
|
July 27, 2011
Genomic loss of the putative tumor suppressor gene E2A in human lymphoma
Anne Steininger, Markus Möbs, Reinhard Ullmann, et al.
International Journal of Radiation Oncology, Biology, Physics
|
May 13, 2026
Reduced-dose total skin electron beam radiotherapy in mycosis fungoides and Sézary syndrome: Systematic review and meta-analysis
Samir Abai, Moritz Fabian Danzer, Chalid Assaf, et al.
Leukemia & Lymphoma
|
January 14, 2012
Vorinostat combined with bexarotene for treatment of cutaneous T-cell lymphoma: in vitro and phase I clinical evidence supporting augmentation of retinoic acid receptor/retinoid X receptor activation by histone deacetylase inhibition
Reinhard Dummer, Marc Beyer, Kenneth Hymes, et al.
European Journal of Cancer (Oxford, England : 1990)
|
April 3, 2017
European Organisation for Research and Treatment of Cancer consensus recommendations for the treatment of mycosis fungoides/Sézary syndrome - Update 2017
Franz Trautinger, Johanna Eder, Chalid Assaf, et al.
Journal of Clinical Pathology
|
October 5, 2006
CD56-positive haematological neoplasms of the skin: a multicentre study of the Cutaneous Lymphoma Project Group of the European Organisation for Research and Treatment of Cancer
Chalid Assaf, Sylke Gellrich, Sean Whittaker, et al.
The Journal of Investigative Dermatology
|
November 21, 2008
Fine-mapping chromosomal loss at 9p21: correlation with prognosis in primary cutaneous diffuse large B-cell lymphoma, leg type
Nancy J Senff, Willem H Zoutman, Maarten H Vermeer, et al.
Page
of 13
Search research articles
Search
Showing results (91-100 of 124) with videos related to
Sort By:
Page
of 13
Proceedings of the National Academy of Sciences of the United States of America
|
March 27, 2009
Gene deregulation and spatial genome reorganization near breakpoints prior to formation of translocations in anaplastic large cell lymphoma
Stephan Mathas, Stephan Kreher, Karen J Meaburn, et al.
Cancers
|
January 10, 2026
Brentuximab Vedotin in Advanced-Stage Mycosis Fungoides/Sézary Syndrome with Low CD30 Expression: Real-World Data from the German Cutaneous Lymphoma Network
Christoph Blazejak, Mathias Oymanns, René Stranzenbach, et al.
Blood
|
May 22, 2023
Dimethyl fumarate treatment in relapsed and refractory cutaneous T-cell lymphoma: a multicenter phase 2 study
Jan P Nicolay, Susanne Melchers, Jana D Albrecht, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
April 8, 2010
Phase II clinical trial of intratumoral application of TG1042 (adenovirus-interferon-gamma) in patients with advanced cutaneous T-cell lymphomas and multilesional cutaneous B-cell lymphomas
Reinhard Dummer, Stefan Eichmüller, Sylke Gellrich, et al.
The Journal of Experimental Medicine
|
July 27, 2011
Genomic loss of the putative tumor suppressor gene E2A in human lymphoma
Anne Steininger, Markus Möbs, Reinhard Ullmann, et al.
International Journal of Radiation Oncology, Biology, Physics
|
May 13, 2026
Reduced-dose total skin electron beam radiotherapy in mycosis fungoides and Sézary syndrome: Systematic review and meta-analysis
Samir Abai, Moritz Fabian Danzer, Chalid Assaf, et al.
Leukemia & Lymphoma
|
January 14, 2012
Vorinostat combined with bexarotene for treatment of cutaneous T-cell lymphoma: in vitro and phase I clinical evidence supporting augmentation of retinoic acid receptor/retinoid X receptor activation by histone deacetylase inhibition
Reinhard Dummer, Marc Beyer, Kenneth Hymes, et al.
European Journal of Cancer (Oxford, England : 1990)
|
April 3, 2017
European Organisation for Research and Treatment of Cancer consensus recommendations for the treatment of mycosis fungoides/Sézary syndrome - Update 2017
Franz Trautinger, Johanna Eder, Chalid Assaf, et al.
Journal of Clinical Pathology
|
October 5, 2006
CD56-positive haematological neoplasms of the skin: a multicentre study of the Cutaneous Lymphoma Project Group of the European Organisation for Research and Treatment of Cancer
Chalid Assaf, Sylke Gellrich, Sean Whittaker, et al.
The Journal of Investigative Dermatology
|
November 21, 2008
Fine-mapping chromosomal loss at 9p21: correlation with prognosis in primary cutaneous diffuse large B-cell lymphoma, leg type
Nancy J Senff, Willem H Zoutman, Maarten H Vermeer, et al.
Page
of 13